FDA Label Updates Transform CAR T-Cell Therapy Access -

FDA Label Updates Transform CAR T-Cell Therapy Access

akshay dhamal / September 2, 2025 / FDA Label Updates Transform CAR T-Cell Therapy Access

The recent U.S. FDA label updates for CAR T-cell therapies, reducing monitoring burdens, demonstrate regulatory adaptation to improve patient access, potentially expanding treatment reach beyond the current 20% eligible patient coverage. This reflects growing confidence in safety and efficacy, representing a model for other regions to emulate. Key Updates from the FDA 1. Removal of […]